JG
CCCC icon

Jain Global’s C4 Therapeutics CCCC Stock Holding History

Jain Global’s Portfolio CCCC Stock Details CCCC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$269K Sell
57,562
-4,828
-8% -$16.5K ﹤0.01% 1431
2026
Q1 		$164K Buy
62,390
+49,628
+389% +$117K ﹤0.01% 1105
2025
Q4 		$24.4K Buy
+12,762
New +$30.2K ﹤0.01% 1181
2025
Q3 		– Sell
-136,219
Closed -$195K – 1076
2025
Q2 		$195K Buy
136,219
+112,016
+463% +$163K ﹤0.01% 981
2025
Q1 		$38.7K Buy
+24,203
New +$72.2K ﹤0.01% 1021

Other funds holding CCCC

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $322M AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Jain Global's CCCC Position: Q2 2026 in Review

Jain Global reduced its C4 Therapeutics (CCCC) stake by 7.7% in Q2 2026, selling an estimated $16.5K and leaving 57,562 shares worth $269K. The position accounts for ﹤0.01% of the portfolio, ranked #1431.

Jain Global first reported a position in CCCC in Q1 2025 and has held it in 5 quarters since. 148 funds tracked by Wall St. Rank hold CCCC as of Q2 2026.

  • Jain Global held 57,562 shares of C4 Therapeutics worth $269K as of Q2 2026.
  • Jain Global sold 4,828 C4 Therapeutics shares in Q2 2026, an estimated $16.5K.
  • C4 Therapeutics made up ﹤0.01% of Jain Global's portfolio in Q2 2026, its #1431 holding.
  • Jain Global first reported a position in C4 Therapeutics in Q1 2025 and has held it in 5 quarters since.
  • 148 funds tracked by Wall St. Rank held C4 Therapeutics as of Q2 2026.

Based on Jain Global's 13F filing for Q2 2026, filed 14 Aug 2026.